Long-term modification of the excretion of prostaglandin E2 by fetal exposure to a maternal low protein diet in the rat

Annals of Nutrition and Metabolism

Volumn 43, Issue 2, 1999, Pages 98-106

  Sherman, Rachel C ^a   Jackson, Alan A ^a   Langley Evans, Simon C ^b  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NORTHAMPTON   (United Kingdom)

Author keywords

15 hydroxyprostaglandin dehydrogenase; Low protein diets; Pregnancy; Programming; Prostaglandin E2

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CASEIN; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DIET; ENZYME ACTIVITY; FEMALE; FETUS; HYPERTENSION; KIDNEY; KIDNEY VASCULAR RESISTANCE; LUNG; MATERNAL NUTRITION; NEWBORN; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN METABOLISM; PROTEIN RESTRICTION; RAT; URINALYSIS;

ANIMALS; DIET, PROTEIN-RESTRICTED; DINOPROSTONE; FEMALE; HYDROXYPROSTAGLANDIN DEHYDROGENASES; KIDNEY; LIVER; PLACENTA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, INBRED SHR; RATS, WISTAR;

EID: 0032791860     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012773     Document Type: Article

References (29)

1. Lucas A: Programming by nutrition in man; in Conning D (ed): Early Diet, Later Consequences. London, British Nutrition Federation, 1992, pp 24-28.
2. Deeming DC, Ferguson MWJ: The mechanism of temperature dependent sex determinations in crocodilians: A hypothesis. Am Zool 1989; 29:973-985.
3. Arai Y, Gorski RA: Critical exposure time for androgenization of the developing hypothalamus in the female rat. Endocrinology 1968;82: 1010-1014.
4. Barker DJP: Mothers, Babies and Disease in Later Life. London, BMJ Publishing Group, 1994.
5. Campbell DM, Hall MH, Barker DJP, Cross J, Shiell AW, Godfrey KM: Diet in pregnancy and the offspring's blood pressure 40 years later. Br J Obstet Gynaecol 1996; 103: 273-280.
6. Langley-Evans SC: Nutritional programming and the development of hypertension; in McCarty R, Blizzard DA, Chevalier RL (eds): Development of the Hypertensive Phenotype: Basic and Clinical Studies. Handbook of Hypertension. Amsterdam, Elsevier, 1998, vol 19, pp 539-574.
7. Sherman RC, Langley-Evans SC: Early administration of angiotensin-converting enzyme inhibitor captopril prevents the development of hypertension programmed by intrauterine exposure to a maternal low protein diet. Clin Sci 1998;94:373-381.
8. Harrap SB, Mirakian C, Datodi SR, Lever AF: Blood pressure and lifespan following brief ACE inhibitor treatment in young spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1994;21:125-127.
9. Scolkens BA, Gehring D, Schlotte V, Weithmann U: Evening primrose oil, a dietary prostaglandin precursor, diminishes vascular reactivity to renin and angiotensin II in rats. Prostaglandins Leukot Med 1982;8: 273-285.
10. 2 interactions in spontaneously hypertensive rats. Hypertension 1993;22:688-698.
11. Dunn MJ: Renal prostaglandin production in the Japanese (Kyoto) spontaneously hypertensive rat. Clin Sci Mol Med Suppl 1978;55: 191-193.
12. Konieczkowski M, Dunn MJ, Stork JE, Hassid A: Glomerular synthesis of prostaglandins and thromboxane in spontaneously hypertensive rats. Hypertension 1983;5:446-452.
13. Tai H-H, Yuan B, Sun M: Metabolism of prostaglandins in spontaneously hypertensive rats: NAD+ dependent 15-hydroxyprostaglandin dehydrogenase activity is decreased in kidney and increased in lung. Life Sci 1979;24:1275-1280.
14. Narce M, Poisson J-P, Belleville J, Chanusot B: Depletion of delta 9 desaturase (EC 1.14.99.5) enzyme activity in growing rat during dietary protein restriction. Br J Nutr 1992;68:627-637.
15. Mercuri O, de Tomas ME, Itarte H: Prenatal protein depletion and delta 9, delta 6 and delta 5 desaturase. Lipids 1979;14:822-825.
16. Langley-Evans SC, Gardner DS, Jackson AA: Association of disproportionate growth of fetal rats in late gestation with raised systolic blood pressure in later life. J Reprod Fertil 1996;106:307-312.
17. Clarke HE, Coates ME, Eva JK, Ford DJ, Milner CK. O'Donoghue PN, Scott PP, Ward RJ: Dietary standards for laboratory animals: Report of the Laboratory Animals Centre Diets Advisory Committee. Lab Anim 1977;11:1-28.
18. Nagai K, Nabekura H, Mibe M, Ohshige T, Mori N: Prostaglandin dehyrogenase activity in placenta and maternal lung, kidney and gastric mucosa during rat pregnancy. Mol Cell Endocrinol 1991;80:153-163.
19. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke MM, Olson BJ, Klenk DC: Measurement of protein using bicinchonic acid. Anal Biochem 1985;150:76-85.
20. Xun C-Q, Ensor CM, Tai H-H: Regulation of synthesis and activity of NAD+ dependent 15 hydroxyprostaglandin dehydrogenase (15-PGDH) by dexamethasone and phorbol ester in human erythroleukemia (HEL) cells. Biochem Biophys Res Commun 1991;177:1258-1265.
21. Franchi AM, Faletti A, Gimeno MF, Gimeno AL: Influence of sex hormones on prostaglandin dehydrogenase activity in the rat uterus. Prostaglandins 1985;29:953-960.
22. Tsai MY, Brown DM: Effect of dexamethasone on fetal lung 15-hydroxy-prostaglandin dehydrogenase: possible mechanism for the prevention of patent ductus arteriosus by maternal dexamethasone therapy. Prostaglandins Leukot Med 1987;27:237-245.
23. Langley-Evans SC, Gardner DS, Jackson AA: Maternal protein restriction influences the programming of the rat hypothalamic-pituitary-adrenal axis. J Nutr 1996;126: 1578-1585.
24. Langley-Evans SC: Hypertension induced by fetal exposure to a maternal low protein diet, in the rat, is prevented by pharmacological blockade of glucocorticoid synthesis. J Hypertens 1997;15:537-544.
25. Gardner DS, Jackson AA, Langley-Evans SC: Maintenance of maternal diet-induced hypertension in the rat is dependent upon glucocorticoids. Hypertension 1997;30:1525-1530.
26. Langley-Evans SC, Welham SJM, Jackson AA: Fetal exposure to a maternal low protein diet impairs nephrogenesis and promotes hypertension in the rat. Life Sci 1999;64: 965-974.
27. Seckl JR: Glucocorticoids, feto-placental 11β-hydroxysteroid dehydrogenase type 2, and the early origins of adult disease. Steroids 1997;62: 89-94.
28. Langley-Evans SC, Phillips GJ, Benediktsson R, Gardner DS, Edwards CRW, Jackson AA, Seckl JR: Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension. Placenta 1996;17:169-172.
29. Baer PG, McGiff JC: Comparison of effects of prostaglandins E2 and I2 on rat renal vascular resistance. Eur J Pharmacol 1979;54:359-363.